Bristol-Myers CEO: We"re "one step closer to creating that great company" with Celgene

Celgene Corp will sell its psoriasis drug Otezla for $13.4 billion in cash to Amgen Inc, taking Celgene a step closer to a $74-billion takeover by Bristol-Myers Squibb Co......»»

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, creating a major pharma company with several blockbuster cancer drugs as competition in the immunotherapy space heats up......»»

Bristol-Myers Squibb is buying Celgene for about $74 billion, creating a major pharma company with several blockbuster cancer drugs as competition in the immunotherapy sector heats up. Fred Katayama reports......»»

Bristol-Myers Squibb Co , which is set to buy biotechnology company Celgene Corp for $74 billion, posted better-than-expected second-quarter profit on Thursday on strong sales of blood thinner Eliquis and rheumatoid arthritis treatment Orencia......»»

Uncertainty over Bristol-Myers Squibb Co (NYSE: BMY)'s impending deal to acquire Celgene Corporation (NASDAQ: CELG) and an adverse clinical trial readout were dragging the shares of the large-cap pharma company lo read more.....»»

Bristol-Myers Squibb Co. said Monday a late-stage study of its Opdivo as a treatment for a type of liver cancer failed to meet its main goals. The company said the Phase 3 study called CheckMate -459 evaluating Opdivo versus sorafenib as a .....»»

U.S drugmaker Bristol-Myers Squibb Co, which is set to buy biotechnology company Celgene Corp for $74 billion, posted slightly better-than-expected first-quarter earnings on Thursday on strong sales of its blockbuster blood thinner Eliquis......»»

Related Stocks: DIS, HBI, COP, CELG, BMY, SYK, INTU, GMRE, PYPL, FOXA, GE,.....»»

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion in a cash-and-stock deal, creating a powerhouse that will have several blockbuster cancer drugs......»»

Bristol-Myers Squibb Co., which has held a major presence in the Tampa Bay area since 2014, has entered into a $74 billion merger agreement to acquire a New Jersey biotechnology company. Under terms of the agreement, Celgene Corp. (NASDAQ: CELG) .....»»

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, creating one of the biggest pharmaceutical companies and combining two significant cancer drug businesses......»»

The cost to insure Bristol-Myers Squibb debt hit its highest point since 2010 on Thursday, following the announcement that the U.S. pharmaceutical company would acquire rival Celgene Corp in a deal worth $74 billion......»»

Bonds issued by Celgene Corp. rallied on Thursday, after Bristol-Myers Squibb Co. said it was acquiring the company in a cash-a.....»»

The cost to insure Bristol-Myers Squibb debt hit its highest point since May 2010 on Thursday, following the announcement that the U.S. pharmaceutical company would acquire rival Celgene Corp in a deal worth about $74 billion......»»

Bristol-Myers Squibb agreed to acquire Celgene for about $74 billion, creating a cancer-drug powerhouse, but one with questions about its long-term prospects......»»

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Bristol-Myers Squibb Company to Acquire Celgene Corporation M&A Conference (Transcript).....»»

Celgene Corp. , the biopharmaceutical company that agreed last week to be acquired by Bristol-Myers Squibb Co. in a mega-deal valued at $74 billion, provided 2019 profit and sales outlooks that were above expectations. The company said it expects a.....»»

Bristol-Myers Squibb Co. said on Wednesday that activist hedge fund Starboard Value LP wants to add five directors to its board and bought one million shares after the pharmaceutical company said it plans to buy biotech company Celgene Corp......»»

Celgene Corporation (CELG)’s stock falls after Wellington Management Company announced that it does not support Bristol-Myers Squibb Co (BMY)’s proposed acquisition. Q4 hedge.....»»

Shares of Virgin Galactic Holdings Inc. rally on Monday after the company gets a step closer to its stated goal of offering space-tourism flights in what Wall Street called a "major milestone" moment......»»